Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy

Area of Science:

• Immunology
• Cardiology
• Pathophysiology

Background:

• Myocarditis is a serious heart condition in children and young adults, often leading to dilated cardiomyopathy (DCM).
• Current diagnostic and therapeutic options for myocarditis and its progression to DCM are limited.
• Understanding the immune mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To characterize the immune effector pathways involved in autoimmune myocarditis and its transition to DCM.
• To establish and utilize a novel T-cell receptor (TCR) transgenic mouse model for studying myocarditis and DCM.
• To identify critical cytokines and immunological processes driving cardiac inflammation and disease progression.

Main Methods:

• Development of a T-cell receptor (TCR) transgenic mouse model exhibiting spontaneous autoimmune myocarditis.
• Utilized cardiac magnetic resonance imaging (MRI) to assess cardiac changes.
• Investigated the role of key cytokines, including Interferon-gamma (IFN-γ) and Interleukin-17A (IL-17A).

Main Results:

• The TCR transgenic mouse model developed spontaneous autoimmune myocarditis progressing to lethal DCM.
• Cardiac MRI showed early inflammation-associated changes, including transient left ventricle wall thickening.
• IFN-γ was identified as a critical cytokine in the initial inflammatory phase.
• Cooperation between IFN-γ and IL-17A was essential for the progression to DCM.

Conclusions:

• The novel TCR transgenic mouse model is a valuable tool for studying autoimmune myocarditis and DCM.
• IFN-γ and IL-17A play critical, cooperative roles in the pathogenesis of myocarditis and its progression to DCM.
• This research provides insights into the immunological underpinnings of myocarditis-induced DCM, paving the way for potential therapeutic targets.